triazoles has been researched along with 3,4-dihydroxyphenylglycol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD | 1 |
Fukaya, M; Hara, Y; Ito, A; Okamoto, H; Sakagami, H; Sugawara, T; Yamauchi, J | 1 |
1 trial(s) available for triazoles and 3,4-dihydroxyphenylglycol
Article | Year |
---|---|
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 1999 |
1 other study(ies) available for triazoles and 3,4-dihydroxyphenylglycol
Article | Year |
---|---|
Cytohesin-2 mediates group I metabotropic glutamate receptor-dependent mechanical allodynia through the activation of ADP ribosylation factor 6 in the spinal cord.
Topics: ADP-Ribosylation Factor 1; ADP-Ribosylation Factor 6; Animals; GTPase-Activating Proteins; Hyperalgesia; Inflammation; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neuralgia; Post-Synaptic Density; Posterior Horn Cells; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Spinal Cord; Spinal Cord Dorsal Horn; Triazoles | 2021 |